SIOPEL-3 Liver Tumour Studies: hepatoblastoma and hepatocellular carcinoma
Not Applicable
Completed
- Conditions
- Hepatoblastoma and hepatocellular carcinomaCancerMalignant neoplasm of liver
- Registration Number
- ISRCTN87675276
- Lead Sponsor
- niversity Hospitals of Leicester NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
1. Diagnosis is hepatoblastoma
2. Pretext is I, II or III
3. No extrahepatic Involvement
4. Age <16 at diagnosis
5. No prior treatment
6. No primary surgery required
7. Lung CT scan performed
8. Initial serum alpha-feta protein value obtained (greater than or 100 ng/ml)
Exclusion Criteria
Pretext 4, extra hepatic disease, lung metastases, tumour rupture.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete resection
- Secondary Outcome Measures
Name Time Method Toxicity measures, survival and event-free survival